Zanaflex Capsules Trademark Details

Zanaflex Capsules was registered on Tuesday, November 20, 2007 and is currently owned by Acorda Therapeutics, Inc. under the registration number 3341341 . This mark is alive with a status of Section 8 & 15-Accepted and Acknowledged. The last case file activity for this mark occured 10 years ago on Saturday, November 30, 2013, according to the United State Patent & Trademark Office
Word Mark Zanaflex Capsules
Status Alive Registered 702 — Section 8 & 15-Accepted and Acknowledged

Current Owner

Acorda Therapeutics, Inc. of Hawthorne, NY

View all trademarks for Acorda Therapeutics, Inc.
Other Trademarks for Acorda Therapeutics, Inc.

Previous Owners

Elan Pharmaceuticals, Inc. of South San Francisco, CA

View all trademarks for Elan Pharmaceuticals, Inc.
Other Trademarks for Elan Pharmaceuticals, Inc.
Serial Number 78713378
Registration Number 3341341
Status Date Saturday, November 30, 2013
Filing Date Saturday, November 30, 2013
Registration Date Tuesday, November 20, 2007
Attorney Joseph C. Guagliardo

Correspondent

Joseph C. Guagliardo
Pepper Hamilton LLP
18th & Arch Streets
Philadelphia PA 19103

Case File Statements

Disclaimer with Predetermined Text "Capsules"
Goods & Services Pharmaceutical preparations containing tizanadine hydrochloride for the treatment of neurological disorders

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Thursday, September 22, 2005
First Use Anywhere Monday, April 4, 2005
First Use In Commerce Monday, April 4, 2005
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.